PolyNovo

PolyNovo Limited (ASX:PNV) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in the United States, Australia, New Zealand, and internationally. With the latest financial year loss of AU$3.2m and a trailing-twelve-month loss of AU$3.7m, the AU$1.4b market-cap company amplified its loss by moving further away from its breakeven target. The most pressing concern for investors is PolyNovo's path to profitability - when will it breakeven? Below we will provide a high-level summary of the industry analysts' expectations for the company.